That was a really smart way to confirm that, as far as FDA is concerned, hyaluronidase is indeed an active ingredient, along with daratumumab, in the formulation of Darzalex Faspro.
The only problem with how you cited the FDA-approved prescribing information/package insert to prove your point is that I didn't think of it first (!)
Market Data 
Markets 
